Sydney Jennings

The uptake among primary care physicians of new migraine drugs has been hindered by 2 significant obstacles, a headache specialist explained to Patient Care Online.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

In a new recommendation statement, the US Preventive Services Task Force concluded that current evidence is insufficient to support broad screening for vitamin D deficiency in adults.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Fatigue was among the most common symptoms that health care workers in Sweden reported 8 months after mild COVID-19 infection, according to a new research letter.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

A single injection of casirivimab and imdevimab reduced the risk for symptomatic SARS-CoV-2 infection by 81% among household contacts of infected persons, according to new phase 3 study results.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Undesired weight changes and rising alcohol intake are a few issues facing adults due to prolonged pandemic-related stress, the latest American Psychological Association Stress in America™ poll reveals.

Global confirmed cases of COVID-19 have surpassed 134 million. Plus more data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

A recent study showed lifestyle counseling in primary care was effective in preventing type 2 diabetes in long-term follow-up.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

The Asthma and Allergy Foundation of America recently released its annual Allergy Capitals™ report. Which cities are most challenging for patients with seasonal allergies?

Black women in the US are dying from COVID-19 at a higher rate than every other sex and racial group, except Black men, according to a new study.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Developed by researchers from the University of Pennsylvania Health System, the model uses a referral management system to support primary care patients with mental health needs.

Which FDA-approved drugs from the first quarter of 2021 should primary care physicians know about? Listen to our newest podcast episode to find out.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

In an April 1, 2021 statement, the FDA announced the authorization of a new multi-dose vial of Moderna's COVID-19 vaccine that contains up to 15 doses.

WalletHub recently compared the most populated US cities to see which ones prioritize residents’ well-being. Find out which areas ranked healthiest and unhealthiest.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

The end of another quarter means a new list of FDA-approved drugs for primary care. Which ones should you know about?

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

New data suggests that the antibody cocktail, bamlanivimab plus etesevimab, reduces the risk of COVID-19-related hospitalizations and death by 87% in high-risk COVID-19 patients.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.